Liberal ‘Evening News’ Blames Drug Industry for TB Scare?

Question by GREAT_AMERICAN: Liberal ‘Evening News’ Blames Drug Industry for TB Scare?
‘Evening News’ Blames Drug Industry for TB Scare
CBS reporter cites lack of vaccine development but excludes industry rebuttal.

The tuberculosis scare led all three major network news broadcasts on May 31. But CBS “Evening News” pointed fingers at one of the network’s favorite targets, the pharmaceutical industry.

Reporter Nancy Cordes compared the lack of vaccinations and treatments of this specific strain of tuberculosis to other “fast-moving infectious diseases,” including SARS, West Nile Virus and Avian Flu.

She followed with the blame game. “Why haven’t more drugs been developed to fight disease with the potential to kill thousands?” asked Cordes, the network’s Transportation and Consumer Safety correspondent.

“Pharmaceutical companies live to make a profit and if antibiotics, for example, because they’re used for usually 7 to 14 days, maybe as long as a month, can’t generate the same kind of profits as a new cholesterol agent or the new Viagra, which a person might take for years,” said Dr. Eric Nuermberger, an assistant professor of Medicine, Division of Infectious Diseases, at Johns Hopkins School of Public Health.

The Associated Press reported that only two other patients with this drug-resistant strain of tuberculosis have been treated at National Jewish Hospital since 2000. With only three cases documented in the last seven years, it would be difficult for the pharmaceutical industry have developed vaccination and treatment for this specific strain. That was a point CBS did not make.

The CBS story also neglected to include a response from the pharmaceutical industry about its development of medications for infectious diseases.

However, Pharmaceutical Research and Manufacturers of America (PHRMA) points out such products are not that easy to develop. There are various hurdles that must be cleared. PHRMA stated new medicines used to treat these diseases “are the result of medical research and development that can take as long as 15 years and cost nearly $ 1 billion to bring a new medicine from the laboratory to a pharmacy shelf.”

A Business & Media Institute study found while covering everything from medical “controversies” to breakthroughs, nearly 80 percent of the stories excluded the viewpoint of the pharmaceutical industry, failing to include either a company statement or a company spokesman.

Best answer:

Answer by Matt
i would have thought they would blame bush first, then everyone else next

What do you think? Answer below!

OETA Story on Meth Madness #1 aired on 12/01/09 – This story aired on the Oklahoma News Report (ONR) on OETA-The Oklahoma Network. The reporter is Lis Exon; photojournalist is Tim Carson. For more information, go to the ONR web site www.news.oeta.tv and ONR blog blog.oeta.tv For more about OETA-The Oklahoma Network, visit www.oeta.tv EVEN BEFORE THE CURRENT STATE BUDGET CRISIS THE DEPARTMENT OF MENTAL HEALTH AND SUBSTANCE ABUSE WAS IN A FINANCIAL CRISIS. MENTAL HEALTH COMMISSIONER TERRI WHITE SAYS ONLY 23 PERCENT OF PEOPLE SEEKING ADDICTION TREATMENT CAN BE HELPED LEAVING THE MAJORITY TO FEND FOR THEMSELVES. IN A SERIES OF REPORTS THIS WEEK WE EXAMINE WHAT HAS TURNED OUT TO BE A LARGELY FAILING EFFORT TO TREAT OKLAHOMA’S METH ADDICITION. OETA’S LIS EXON HAS PART ONE OF METH MADNESS.

Special Report: New drugs, fresh hope for autism patients | The Republic

Filed under: drug treatment news stories

For years the best that doctors have been able to offer patients with autism is intensive therapy and anti-psychotic drugs such as Johnson & Johnson's Risperdal to blunt some of the extreme behaviors associated with their disorder – tantrums, …
Read more on The Republic

Groups call for halt to marketing of opioids for long-term pain

Filed under: drug treatment news stories

Such a move would help curb the rapid increase of overdoses and addiction that has been fueled by the powerful narcotics, said Andrew Kolodny, president of Physicians for Responsible Opioid Prescribing. Others countered at a two-day meeting such a …
Read more on Milwaukee Journal Sentinel

Joshua Boger: Seeking a cure for childhood blindness

Filed under: drug treatment news stories

It's hard for outsiders to see the difference between a worthy specialty drug that can have a transformative impact and a drug used on a bigger population but which has a lesser impact. (Alkeus is working to establish proof-of-concept for its ALK-001 …
Read more on Mass High Tech